Hydrofluoroalkane-134A Beclomethasone or Chlorofluorocarbon Fluticasone: Effect on Small Airways in Poorly Controlled Asthma

References

• National Heart Lung and Blood Institute of the National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma, Expert Panel Report 2; NIH Publication No. 97-4051. Bethesda, MD: NIH, NHLBI, 1997.
   Google Scholar
• Hamid Q, Song Y, Kotsimbos T C, Minshall E, Bai T R, Hegele R G, Hogg J C. Inflammation of small airways in asthma? J Allergy Clin Immunol 1997; 100:44–51. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kraft M. The distal airways: are they important in asthma? Eur Respir J 1999; 14:1403–1417. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Newman S P. A comparison of lung deposition patterns between different asthma inhalers. J Aerosol Med 1995; 8(suppl 3):S21–S26. discussion S27. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Leach C L, Davidson P J, Hasselquist B E, Boudreau R J. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002; 122:510–516. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 2001; 323:253–256. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136:225–244.
   PubMed Web of Science ®Google Scholar
• Gold W. Pulmonary function testing. In: Murray J F, Nadal J A, Mason R J, Boushey H A Jr, eds. Textbook of Respiratory Medicine. Philadelphia, PA: WB Saunders Co., 2000.
   Google Scholar
• SAS, SAS/STAT User's Guide Vol. 8. Cary, NC: SAS Institue, Inc., 1999.
   Google Scholar
• Louis R, Lau L C, Bron A O, Roldaan A C, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161:9–16. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fairfax A, Hall I, Spelman R. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Ann Allergy Asthma Immunol 2001; 86:575–582. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gross G, Thompson P J, Chervinsky P, Vanden Burgt J. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma. Chest 1999; 115:343–351. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Magnussen H. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG). Respir Med 2000; 94:549–555. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Worth H, Muir J F, Pieters W R. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration 2001; 68:517–526. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout F J, Laitinen L A. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma. Int J Clin Pract 2001; 55:100–106. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Goldin J G, Tashkin D P, Kleerup E C, Greaser L E, Haywood U M, Sayre J W, Simmons M D, Suttorp M, Colice G L, Vanden Burgt J A, Aberle D R. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999; 104:258–267.
   PubMed Web of Science ®Google Scholar
• Kraft M, Martin R J, Wilson S, Djukanovic R, Holgate S T. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999; 159:228–234., [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wagner E M, Bleecker E R, Permutt S, Liu M C. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 1998; 157:447–452. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cosio M, Ghezzo H, Hogg J C, Corbin R, Loveland M, Dosman J, Macklem P T. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298:1277–1281. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wright J L, Lawson L M, Pare P D, Kennedy S, Wiggs B, Hogg J C. The detection of small airways disease. Am Rev Respir Dis 1984; 129:989–994. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Busse W W, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice G L. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999; 104:1215–1222. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar